Search research articles
Contact Us
Filters
Showing results (41-50 of 362) with videos related to
Page
of 37
Sort By:
Expert Review of Clinical Pharmacology
|
November 6, 2012
Evidence-based guidelines for pediatric clinical trials: focus on StaR Child Health
Mario R Sampson, Daniel K Benjamin, Michael Cohen-Wolkowiez
Expert Opinion on Pharmacotherapy
|
April 7, 2015
Advances in the treatment of invasive neonatal candidiasis
Lorena Botero-Calderon, Daniel K Benjamin, Michael Cohen-Wolkowiez
Early Human Development
|
February 2, 2010
Risk factors and prevention of late-onset sepsis in premature infants
L Corbin Downey, P Brian Smith, Daniel K Benjamin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
July 9, 2005
Invasive Candida infections in the neonate
P Brian Smith, William J Steinbach, Daniel K Benjamin
Expert Opinion on Pharmacotherapy
|
August 10, 2005
Neonatal candidiasis: prophylaxis and treatment
Kenneth F Tiffany, Phillip B Smith, Daniel K Benjamin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 2, 2005
Antifungal treatment in pediatric patients
Theoklis E Zaoutis, Daniel K Benjamin, William J Steinbach
Pediatrics
|
December 7, 2021
School Safety, Masking, and the Delta Variant
Angelique E Boutzoukas, Kanecia O Zimmerman, Daniel K Benjamin
American Journal of Perinatology
|
June 26, 2019
Neonatal Therapeutics: Considerations for Dosing
Kanecia O Zimmerman, Daniel K Benjamin, Mara L Becker
The Pediatric Infectious Disease Journal
|
April 26, 2012
Use of the complete blood cell count in late-onset neonatal sepsis
Christoph P Hornik, Daniel K Benjamin, Kristian C Becker, et al.
The Pediatric Infectious Disease Journal
|
April 26, 2012
Use of the complete blood cell count in early-onset neonatal sepsis
Christoph P Hornik, Daniel K Benjamin, Kristian C Becker, et al.
Page
of 37
Search research articles
Search
Showing results (41-50 of 362) with videos related to
Sort By:
Page
of 37
Expert Review of Clinical Pharmacology
|
November 6, 2012
Evidence-based guidelines for pediatric clinical trials: focus on StaR Child Health
Mario R Sampson, Daniel K Benjamin, Michael Cohen-Wolkowiez
Expert Opinion on Pharmacotherapy
|
April 7, 2015
Advances in the treatment of invasive neonatal candidiasis
Lorena Botero-Calderon, Daniel K Benjamin, Michael Cohen-Wolkowiez
Early Human Development
|
February 2, 2010
Risk factors and prevention of late-onset sepsis in premature infants
L Corbin Downey, P Brian Smith, Daniel K Benjamin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
July 9, 2005
Invasive Candida infections in the neonate
P Brian Smith, William J Steinbach, Daniel K Benjamin
Expert Opinion on Pharmacotherapy
|
August 10, 2005
Neonatal candidiasis: prophylaxis and treatment
Kenneth F Tiffany, Phillip B Smith, Daniel K Benjamin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 2, 2005
Antifungal treatment in pediatric patients
Theoklis E Zaoutis, Daniel K Benjamin, William J Steinbach
Pediatrics
|
December 7, 2021
School Safety, Masking, and the Delta Variant
Angelique E Boutzoukas, Kanecia O Zimmerman, Daniel K Benjamin
American Journal of Perinatology
|
June 26, 2019
Neonatal Therapeutics: Considerations for Dosing
Kanecia O Zimmerman, Daniel K Benjamin, Mara L Becker
The Pediatric Infectious Disease Journal
|
April 26, 2012
Use of the complete blood cell count in late-onset neonatal sepsis
Christoph P Hornik, Daniel K Benjamin, Kristian C Becker, et al.
The Pediatric Infectious Disease Journal
|
April 26, 2012
Use of the complete blood cell count in early-onset neonatal sepsis
Christoph P Hornik, Daniel K Benjamin, Kristian C Becker, et al.
Page
of 37